447 related articles for article (PubMed ID: 23341160)
21. Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion.
Lorente L; Jiménez A; Martín MM; Iribarren JL; Jiménez JJ; Mora ML
Int J Antimicrob Agents; 2009 May; 33(5):464-8. PubMed ID: 19150225
[TBL] [Abstract][Full Text] [Related]
22. Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?
Kim A; Sutherland CA; Kuti JL; Nicolau DP
Pharmacotherapy; 2007 Nov; 27(11):1490-7. PubMed ID: 17963458
[TBL] [Abstract][Full Text] [Related]
23. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
24. Development and implementation of a piperacillin-tazobactam extended infusion guideline.
Heinrich LS; Tokumaru S; Clark NM; Garofalo J; Paek JL; Grim SA
J Pharm Pract; 2011 Dec; 24(6):571-6. PubMed ID: 21676847
[TBL] [Abstract][Full Text] [Related]
25. Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.
Cutro SR; Holzman R; Dubrovskaya Y; Chen XJ; Ahuja T; Scipione MR; Chen D; Papadopoulos J; Phillips MS; Mehta SA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4470-5. PubMed ID: 24867975
[TBL] [Abstract][Full Text] [Related]
26. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.
Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Lipman J
Clin Infect Dis; 2013 Jan; 56(2):236-44. PubMed ID: 23074313
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic/pharmacodynamic target attainment of intravenous β-lactam regimens against Gram-negative bacteria isolated in a Brazilian teaching hospital.
Furtado GH; Cardinal L; Macedo RS; Silva JO; Medeiros EA; Kuti JL; Nicolau DP
Rev Soc Bras Med Trop; 2015; 48(5):539-45. PubMed ID: 26516962
[TBL] [Abstract][Full Text] [Related]
28. Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.
Guervil DJ; Chau T
Crit Care Nurs Q; 2013; 36(4):345-55. PubMed ID: 24002425
[TBL] [Abstract][Full Text] [Related]
29. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
Taccone FS; Laterre PF; Dugernier T; Spapen H; Delattre I; Wittebole X; De Backer D; Layeux B; Wallemacq P; Vincent JL; Jacobs F
Crit Care; 2010; 14(4):R126. PubMed ID: 20594297
[TBL] [Abstract][Full Text] [Related]
30. [The vicissitude of pathogenic bacteria isolated from critically ill patients in an intensive care unit during a period of using antibiotics].
Wei HJ; Liu LL; Xiaoli LY; Wang YP; Huang D; Pian HY; Zhu YC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jan; 21(1):36-9. PubMed ID: 19141190
[TBL] [Abstract][Full Text] [Related]
31. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S
Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510
[TBL] [Abstract][Full Text] [Related]
32. Identifying critically ill patients at risk for inappropriate antibiotic therapy: a pilot study of a point-of-care decision support alert.
Micek ST; Heard KM; Gowan M; Kollef MH
Crit Care Med; 2014 Aug; 42(8):1832-8. PubMed ID: 24751497
[TBL] [Abstract][Full Text] [Related]
33. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
34. Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa.
Cotrina-Luque J; Gil-Navarro MV; Acosta-García H; Alfaro-Lara ER; Luque-Márquez R; Beltrán-García M; Bautista-Paloma FJ
Int J Clin Pharm; 2016 Feb; 38(1):70-9. PubMed ID: 26474861
[TBL] [Abstract][Full Text] [Related]
35. Restriction of third-generation cephalosporin use decreases infection-related mortality.
Du B; Chen D; Liu D; Long Y; Shi Y; Wang H; Rui X; Cui N
Crit Care Med; 2003 Apr; 31(4):1088-93. PubMed ID: 12682477
[TBL] [Abstract][Full Text] [Related]
36. Continuous infusion beta-lactams for intensive care unit pulmonary infections.
Frei CR; Burgess DS
Clin Microbiol Infect; 2005 May; 11(5):418-21. PubMed ID: 15819874
[TBL] [Abstract][Full Text] [Related]
37. A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.
Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J;
Am J Respir Crit Care Med; 2015 Dec; 192(11):1298-305. PubMed ID: 26200166
[TBL] [Abstract][Full Text] [Related]
38. Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients.
Shea KM; Cheatham SC; Wack MF; Smith DW; Sowinski KM; Kays MB
Int J Antimicrob Agents; 2009 Nov; 34(5):429-33. PubMed ID: 19726163
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
[TBL] [Abstract][Full Text] [Related]
40. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
